Keyphrases
Comprehensive Evaluation
100%
Hepatocellular Carcinoma
100%
Prognostic Value
100%
Immune Infiltration
100%
KDM1
100%
Overall Survival
20%
Genetic Modification
20%
High-level Expression
20%
MRNA Expression
10%
Breast Cancer
10%
Infiltration
10%
Signaling Pathway
10%
Malignancy
10%
Prostate Cancer
10%
Immune Cells
10%
Therapeutic Target
10%
Neuroblastoma
10%
Prognostic Biomarker
10%
Novel Therapeutic Targets
10%
MiRNA Target
10%
Disease-free Survival
10%
Differential Expression
10%
Multi-omics Analysis
10%
Dysregulated
10%
Hepatocellular Carcinoma Treatment
10%
Amine Oxidase
10%
Data-driven Study
10%
KDM1A
10%
Tumor Progression Marker
10%
KDM1B
10%
Biological Interaction Networks
10%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Gene Mutation
100%
Immunocompetent Cell
100%
Immunity
100%
MicroRNA
50%
Tumor Progression
50%
Disease Free Survival
50%
Cell Infiltration
50%
Monoamine Oxidase
50%
Messenger RNA
50%
Immunology and Microbiology
Immune Cell Infiltration
100%
Gene Mutation
66%
Overall Survival
66%
Immunocompetent Cell
33%
Prognostic Biomarker
33%
Disease Free Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Overall Survival
28%
Breast Cancer
14%
Prostate Cancer
14%
Tumor Growth
14%
Neuroblastoma
14%
Biological Marker
14%
microRNA
14%
Molecular Target
14%
Disease Free Survival
14%
Amine Oxidase (Flavin Containing)
14%
Messenger RNA
14%